Diphenhydramine Capsule Franchise in Ahmedabad

Anti-Allergic Capsule Supplier in Mumbai

Antihistamine Medicine Distributor in Delhi

Allergy Care Pharma Franchise in Bangalore

Diphenhydramine Capsule Stockist in Hyderabad
Anti-Allergic & Antihistamine Capsule Manufacturer & Exporter in Chandigarh

Home/Products /diphenhydramine-25mg-capsule

Cufsniff 25 Capsule

Composition : Diphenhydramine (25mg) Capsule

Dosage Form : Capsule

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Cufsniff 25 Capsule contains Diphenhydramine 25mg, an effective antihistamine for managing allergy symptoms, cold, and cough. It works by blocking histamine receptors, reducing sneezing, itching, and other allergic reactions.

It is widely used for seasonal allergies, allergic rhinitis, urticaria, and cold-related discomfort, ensuring quick and reliable symptom relief for patients.

For franchise partners, Cufsniff 25 Capsule is a high-demand anti-allergic product, offering consistent orders and strong prescriber trust, making it a profitable addition to your anti-allergic portfolio.

With increasing prevalence of allergies and respiratory conditions, Cufsniff 25 Capsule provides sustainable business opportunities, allowing partners to strengthen their presence in the anti-allergic and antihistamine therapy segment.

Read More

About the Product

Cufsniff 25 Capsule contains Diphenhydramine 25mg, an effective antihistamine for managing allergy symptoms, cold, and cough. It works by blocking histamine receptors, reducing sneezing, itching, and other allergic reactions.

It is widely used for seasonal allergies, allergic rhinitis, urticaria, and cold-related discomfort, ensuring quick and reliable symptom relief for patients.

For franchise partners, Cufsniff 25 Capsule is a high-demand anti-allergic product, offering consistent orders and strong prescriber trust, making it a profitable addition to your anti-allergic portfolio.

With increasing prevalence of allergies and respiratory conditions, Cufsniff 25 Capsule provides sustainable business opportunities, allowing partners to strengthen their presence in the anti-allergic and antihistamine therapy segment.

Common side effects may include drowsiness, dizziness, dry mouth, blurred vision, or mild gastrointestinal disturbances. Some patients may experience headache, restlessness, or urinary retention. Severe reactions are rare but should be reported immediately to a healthcare professional.

Cufsniff 25 Capsule is indicated for the relief of allergic conditions including rhinitis, urticaria (hives), hay fever, and other histamine-mediated reactions. It may also be used to alleviate symptoms of the common cold and for short-term management of insomnia due to its sedative effect.

Cufsniff 25 Capsule should be taken as prescribed, and caution is advised when driving or operating machinery due to potential drowsiness. It is contraindicated in patients with hypersensitivity to Diphenhydramine, glaucoma, or severe urinary retention. Avoid alcohol during therapy as it may enhance sedative effects.

Store Cufsniff 25 Capsule in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children and do not use beyond the expiry date indicated on the packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation